SCHEMBL284790

SCHEMBL284790

[CH2]CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC

nearest known ligand 0.61

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.61
THRB P10828 1/20 0.61
DNM1 Q05193 6/20 0.44
ALDH1A1 P00352 3/20 0.44
LMNA P02545 2/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
HSD17B10 Q99714 1/20 0.44
SLC22A1 O15245 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1878825 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL8420 1.00
SCHEMBL629331 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL158879 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL8462 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL1874289 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL144689 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL2187 1.00
SCHEMBL3056 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA
SCHEMBL199711 1.00 TSHR (0.61) TSHRTHRBDNM1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 405 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018050484-A1 LUBRICANT COMPOSITIONS CONTAINING DIUREA COMPOUNDS BASF SE (DE) 2018-03-22 WO claimed
EP-3293246-A1 LUBRICANT COMPOSITIONS CONTAINING DIUREA COMPOUNDS BASF SE (DE) 2018-03-14 EP claimed
WO-2014060651-A1 METHOD OF DISSOLVING LIGNOCELLULOSIC MATERIALS METSÄ FIBRE OY (FI) 2014-04-24 WO claimed
US-7786209-B2 Nanostructured particles, phase change inks including same and methods for making same XEROX CORPORATION (US) 2010-08-31 US claimed
US-20080103250-A1 NANOSTRUCTED PARTICLES, PHASE CHANGE INKS INCLUDING SAME AND METHODS FOR MAKING SAME XEROX CORPORATION (US) 2008-05-01 US claimed
WO-2007149842-A2 METHOD OF PREPARING IMIDAZOLIUM SURFACTANTS BRIDGESTONE CORPORATION (JP) 2007-12-27 WO claimed
US-20070293684-A1 Method of preparing imidazolium surfactants BRIDGESTONE CORPORATION 2007-12-20 US claimed
US-20070161734-A1 Comprising clay and cationic mediator such as imidazolium compound wherein cationic mediator comprises hydrophobic unit and cationic unit; use in preparing products such as tires with improved and well-balanced properties including gas impermeability, cure rates, and superior mechanical characteristics BRIDGESTONE CORPORATION (JP) 2007-07-12 US claimed
US-20060173115-A1 Nano-composite and compositions manufactured thereof BRIDGESTONE CORPORATION (JP) 2006-08-03 US claimed
EP-4396311-A1 LUBRICATING COMPOSITION WITH IMPROVED COLD THICKENING PROPERTIES TotalEnergies OneTech (FR) 2024-07-10 EP disclosed
US-20240208990-A1 SPIRO-COMPOUNDS AND COMPOSITIONS INCLUDING THE SAME SOLVENTUM INTELLECTUAL PROPERTIES COMPANY 2024-06-27 US disclosed
CN-118146744-A Adhesive composition, laminate, adhesive film, adhesive layer for optical film, image display device, and polarizing plate 藤森工业株式会社 2024-06-07 CN disclosed
WO-2024116991-A1 WEAR INHIBITOR AND LUBRICATING OIL COMPOSITION 三洋化成工業株式会社 2024-06-06 WO disclosed
WO-2024116990-A1 FRICTION MODIFIER AND LUBRICANT COMPOSITION 三洋化成工業株式会社 2024-06-06 WO disclosed
US-4118352-A CONTAINING 2,6,7-TRIOXA-1-PHOSPHABICYCLO(2.2.2.)OCTANE RING HOECHST AKTIENGESELLSCHAFT (DE) 1978-10-03 US disclosed
US-4080307-A AMMONIUM SALTS OF 1,3-OXA- OR 1,3-THIA-PHOSPHETANES CIBA-GEIGY AG (CH) 1978-03-21 US disclosed
US-4053493-A MICROSTRUCTURE, THERMAL STABILITY, THIXOTROPY EXXON RESEARCH & ENGINEERING CO. (US) 1977-10-11 US disclosed
US-4000081-A LIME SOAP DISPERSANT COMPOUNDS CHEVRON RESEARCH COMPANY (US) 1976-12-28 US disclosed
US-3959334-A 2-HYDROCARBYL-1,4-BUTANEDIOL DISULFATES CHEVRON RESEARCH COMPANY (US) 1976-05-25 US disclosed
US-3953392-A EPOXY COMPOUND AS LUBRICANT DAICEL LTD. (JA) 1976-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240208990-A1 SPIRO-COMPOUNDS AND COMPOSITIONS INCLUDING THE SAME REN, PKD1, SAV1 TSHR 988/4885THRB 504/4885DNM1 3723/4885
US-20070293684-A1 Method of preparing imidazolium surfactants SMARCC2, SMARCC1, ITPR3 TSHR 2080/4885THRB 3466/4885DNM1 2201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.